Enterisol Ileitis Lyophilisate and Solvent for Oral Suspension for Pigs

Nazione: Regno Unito

Lingua: inglese

Fonte: VMD (Veterinary Medicines Directorate)

Principio attivo:

Lawsonia intracellularis

Commercializzato da:

Boehringer Ingelheim Animal Health UK Ltd

Codice ATC:

QI09AE04

INN (Nome Internazionale):

Lawsonia intracellularis

Forma farmaceutica:

Oral lyophilisate

Tipo di ricetta:

POM-V - Prescription Only Medicine – Veterinarian

Gruppo terapeutico:

Pigs

Area terapeutica:

Live Bacterial Vaccine

Stato dell'autorizzazione:

Authorized

Data dell'autorizzazione:

2005-05-16

Scheda tecnica

Revised: March 2021
AN: 00062/2020
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Enterisol Ileitis lyophilisate and solvent for oral suspension for
pigs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dose (2 ml) contains:
Lyophilisate:
ACTIVE SUBSTANCE:
Live attenuated _Lawsonia intracellularis _(MS B3903): 10
4.9
-
10
6.1
TCID
50
*
* Tissue Culture Infective Dose 50%
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Lyophilisate and solvent for oral suspension.
Lyophilisate: light yellow to gold
Solvent: clear, colourless solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Pigs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For active immunisation of weaned pigs from 3 weeks of age and older
to reduce the
intestinal lesions caused by _Lawsonia intracellularis_ infection and
to reduce growth
variability and loss of weight gain associated with the disease.
Under field conditions, the difference in average daily weight gain
was seen to be up to
30 g/day when vaccinated pigs were compared to unvaccinated pigs.
Onset of immunity:
as early as 3 weeks post vaccination.
Duration of immunity:
for at least 17 weeks.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Revised: March 2021
AN: 00062/2020
Page 2 of 6
Vaccinate healthy animals only.
THE VACCINE HAS NOT BEEN TESTED IN BREEDING BOARS.
THEREFORE, THE VACCINATION OF BREEDING BOARS IS NOT RECOMMENDED.
DO NOT VACCINATE ANIMALS WHICH ARE RECEIVING TREATMENT WITH
ANTIMICROBIALS EFFECTIVE
AGAINST _LAWSONIA SPP._ SUCH ANTIMICROBIALS SHOULD BE WITHHELD FOR A
MINIMUM OF 3
DAYS BEFORE AND 3 DAYS AFTER THE DAY OF VACCINATION (SEE SECTION 4.8).
EFFICACY OF REVACCINATION IS UNKNOWN.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals.
In case of anaphylactic reactions, appropriate symptomatic treatment
including the
administration of glucocorticoids, adrenaline, or antihistamines is
recommended.
The vaccine is an attenuated live vaccine and the potential for